Patten & Patten Inc Edwards Lifesciences Corp Transaction History

Patten & Patten Inc

$1.43 Billion
Q4 2024

A detailed history of Patten & Patten Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Patten & Patten Inc holds 154,180 shares of EW stock, worth $11.7 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

154,180

Previous 164,904 6.5%

Holding current value

$11.7 Million

Previous $10.9 Million 4.88%

% of portfolio

0.8%

Previous 0.76%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$64.54 - $75.92 $692,126 - $814,166	-10,724 Reduced 6.5%	154,180 $11.4 Million
Q3 2024 Nov 04, 2024	BUY	$59.7 - $93.78 $687,266 - $1.08 Million	11,512 Added 7.5%	164,904 $10.9 Million
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $258,801 - $289,531	-3,070 Reduced 1.96%	153,392 $14.2 Million
Q1 2024 May 10, 2024	SELL	$72.54 - $95.56 $432,701 - $570,015	-5,965 Reduced 3.67%	156,462 $15 Million
Q4 2023 Jan 23, 2024	SELL	$61.71 - $77.76 $827,901 - $1.04 Million	-13,416 Reduced 7.63%	162,427 $12.4 Million
Q3 2023 Oct 27, 2023	SELL	$69.28 - $93.38 $165,994 - $223,738	-2,396 Reduced 1.34%	175,843 $12.2 Million
Q2 2023 Jul 14, 2023	SELL	$81.41 - $94.33 $230,797 - $267,425	-2,835 Reduced 1.57%	178,239 $16.8 Million
Q1 2023 Apr 25, 2023	SELL	$74.26 - $84.51 $92,602 - $105,383	-1,247 Reduced 0.68%	181,074 $15 Million
Q4 2022 Feb 01, 2023	SELL	$68.3 - $87.44 $87,424 - $111,923	-1,280 Reduced 0.7%	182,321 $13.6 Million
Q3 2022 Oct 19, 2022	SELL	$82.37 - $107.29 $135,086 - $175,955	-1,640 Reduced 0.89%	183,601 $15.2 Million
Q2 2022 Aug 02, 2022	SELL	$86.5 - $128.27 $575,225 - $852,995	-6,650 Reduced 3.47%	185,241 $17.6 Million
Q1 2022 Apr 25, 2022	SELL	$101.96 - $128.34 $175,167 - $220,488	-1,718 Reduced 0.89%	191,891 $22.6 Million
Q4 2021 Jan 26, 2022	SELL	$106.37 - $130.68 $208,485 - $256,132	-1,960 Reduced 1.0%	193,609 $25.1 Million
Q3 2021 Oct 22, 2021	SELL	$102.91 - $122.75 $101,263 - $120,786	-984 Reduced 0.5%	195,569 $22.1 Million
Q2 2021 Jul 13, 2021	SELL	$83.84 - $104.76 $467,827 - $584,560	-5,580 Reduced 2.76%	196,553 $20.4 Million
Q1 2021 Apr 23, 2021	BUY	$78.68 - $90.67 $6,294 - $7,253	80 Added 0.04%	202,133 $16.9 Million
Q4 2020 Jan 19, 2021	BUY	$71.69 - $91.23 $51,831 - $65,959	723 Added 0.36%	202,053 $18.4 Million
Q3 2020 Oct 08, 2020	SELL	$67.19 - $87.44 $228,983 - $297,995	-3,408 Reduced 1.66%	201,330 $16.1 Million
Q2 2020 Jul 21, 2020	BUY	$57.54 - $76.95 $7.81 Million - $10.4 Million	135,795 Added 196.97%	204,738 $14.1 Million
Q1 2020 Apr 16, 2020	SELL	$52.41 - $81.0 $132,125 - $204,201	-2,521 Reduced 3.53%	68,943 $13 Million
Q4 2019 Jan 13, 2020	SELL	$71.7 - $82.09 $30,472 - $34,888	-425 Reduced 0.59%	71,464 $16.7 Million
Q3 2019 Oct 15, 2019	SELL	$61.55 - $75.43 $248,046 - $303,982	-4,030 Reduced 5.31%	71,889 $15.8 Million
Q2 2019 Jul 11, 2019	SELL	$55.74 - $64.41 $129,316 - $149,431	-2,320 Reduced 2.97%	75,919 $14 Million
Q1 2019 Apr 23, 2019	SELL	$47.89 - $64.05 $293,182 - $392,114	-6,122 Reduced 7.26%	78,239 $15 Million
Q4 2018 Jan 17, 2019	SELL	$46.41 - $56.94 $72,817 - $89,338	-1,569 Reduced 1.83%	84,361 $12.9 Million
Q3 2018 Oct 17, 2018	BUY	$45.7 - $58.03 $28,562 - $36,268	625 Added 0.73%	85,930 $15 Million
Q2 2018 Jul 18, 2018	BUY	$42.45 - $51.3 $312,049 - $377,106	7,351 Added 9.43%	85,305 $12.4 Million
Q1 2018 Apr 20, 2018	SELL	$37.19 - $47.45 $36,855 - $47,022	-991 Reduced 1.26%	77,954 $10.9 Million
Q4 2017 Jan 22, 2018	BUY	$33.79 - $39.39 $570,882 - $665,494	16,895 Added 27.23%	78,945 $8.9 Million
Q3 2017 Oct 12, 2017	BUY	$36.29 - $38.83 $2.25 Million - $2.41 Million	62,050	62,050 $6.78 Million

Others Institutions Holding EW

# of Institutions

1,370

Shares Held

482M

Call Options Held

9.66M

Put Options Held

3.83M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.

Account

Patten & Patten Inc Edwards Lifesciences Corp Transaction History